Pembrolizumab with or without chemotherapy versus chemotherapy alone for patients with PD-L1-positive advanced gastric or gastroesophageal junction adenocarcinoma: Update from the phase 3 KEYNOTE-062 trial

ZA Wainberg, K Shitara, E Van Cutsem, L Wyrwicz, KW Lee, I Kudaba, M Garrido, HCC Chung, J Lee, HR Castro-Salguero, W Mansoor, MI Braghiroli, N Karaseva, E Goekkurt, H Satake, J Chao, U Kher, S Shah, P Bhagia, J Tabernero

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article number243
JournalJournal of Clinical Oncology
Issue number4S
Publication statusPublished - 1 Feb 2022
Externally publishedYes
EventASCO Gastrointestinal Cancers Symposium 2022 - San Francisco, United States
Duration: 20 Jan 202222 Jan 2022

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this